期刊文献+

伊布利特与胺碘酮对心房扑动、心房颤动的疗效对比及护理特点 被引量:1

下载PDF
导出
摘要 目的:探讨伊布利特与胺碘酮转复心房扑动/心房颤动的疗效差异及护理特点。方法:将85例符合入选条件的心房扑动/心房颤动病人随机分为两组,分别使用伊布利特与胺碘酮治疗,转复为有效,未转复为无效。结果:伊布利特组对房扑复律疗效明显优于胺碘酮组(P<0.01),对房颤的复律效果也优于胺碘酮组(P<0.05)。结论:伊布利特对房扑/房颤复律效果优于胺碘酮,但需严格监护及护理观察。
作者 房波 施林生
出处 《亚太传统医药》 2012年第2期218-219,共2页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献2

二级参考文献8

  • 1Miller MR, McNamara RL, Segal JB,et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a Meta analysis of clinical trials. J Fam Pract,2000,49:1033-1046.
  • 2Cropp Js, Antal EG, Talbert RL,et al. Ibutilide: a new class Ⅲ antiarrhythmic agent. Parmarcotherapy, 1997,17:1-9.
  • 3Lych JR, Baskin EP, Nutt EM, et al, Comparision of binding to rapidly activating delayed rectifier K channel, Ikr and effects on myocardial refractoriness for class Ⅲ antiarrythmic agents. J Cardiovasc Pharmacol, 1995,25:336-340.
  • 4Naccarelli GV, Lee KS, Gibson JK, et al. Electrophysiology and pharmacology of Ibutilide. Am J Cardiol,1996,78(8A): 12-16.
  • 5Baskin EP , Lynch JJ Jr. Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers. Pharmacol Exp Ther, 1998,285:135-142.
  • 6Ellenbogen KA, Stambler BS, Wood MA, et al . Efficacy of intravenous Ibutilide for rapid termination of atrial fibrillation and atril flutter: a dose-response study. J Am Coll Cardiol, 1996, 28: 130-136.
  • 7Gowdw RM, Punukollu G, Khan LA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther, 2003,10: 259-263.
  • 8Kowey PR, Vanderlugt JT, Luderer JR. Safety and risk/benefit analysis of Ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol , 1996,78 (suppl 8A): 46-52.

共引文献46

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部